Skip to content
Screener

CapEx at other companies

Eli Lilly logo
Eli LillyLLY
$2.93B+72.8%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$275K+75.2%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$78K+255%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$32K-98.7%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$4.72M+179%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$473K-31.9%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.17B+41.2%
Enterprise value$2.18B+31.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001935979-26-000045
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from investing activities:
Proceeds from maturities of marketable securities35,000210,000
Purchases of marketable securities(19,788)(44,660)
Purchases of property and equipment(461)
Net cash provided by investing activities15,212164,879
Cash flows from financing activities:
Proceeds from issuance of common shares178,884
Proceeds from issuance of common shares under 2022 Equity Incentive Plan132369

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's capex?
Biohaven (BHVN) reported capex of $0 in Q1 2026.
How has Biohaven's capex changed year-over-year?
Biohaven's capex decreased by 100.0% year-over-year, from $461K to $0.
What is the long-term trend for Biohaven's capex?
Over 3 years (2022 to 2025), Biohaven's capex has grown at a -51.0% compound annual growth rate (CAGR), from $6.07M to $715K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Biohaven's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude